Posted on 2/21/17
emsCharts Announces Partnership with HealthCall
WARRENDALE, Pa.--(BUSINESS WIRE)--emsCharts, a leading provider of dynamic electronic data collection and management solutions for the emergency medical field, announces a partnership to integrate with HealthCall’s . . .
Posted on 2/17/17
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Warfarin may have dominanted the $10 billion market for anticoagulants for the past 50 or so years, but a new class of drugs that works in . . .
Posted on 2/17/17
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
"A billion here, a billion there, and pretty soon you're talking about real money."It's debatable who first uttered that phrase. What isn't debatable, though, is that . . .
Posted on 2/17/17
Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" . . .
Posted on 2/17/17
Helius Medical Technologies Closes C$12.5 Million Public Offering
NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (TSX: HSM, OTCQB: HSDT) announced the closing of its previously announced public offering of 6,555,000 shares of Class A Common . . .
Posted on 2/16/17
Johnson & Johnson Is Not Cheap, And It Never Will Be
Johnson & Johnson (NYSE:JNJ) has been one of the most consistent and successful companies on earth. It is a company that is truly global in scale, . . .
Posted on 2/16/17
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next Decade
For many investors, Johnson & Johnson (NYSE:JNJ) is the quintessential set-it-and-forget-it investment in the healthcare arena. It's the largest publicly traded healthcare company by a mile, . . .
Posted on 2/16/17
Windtree Therapeutics Completes $10.5 Million Private Offering
Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has completed a $10.5 . . .
Posted on 2/15/17
Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship
Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has entered into a relationship with . . .
Posted on 2/15/17
Integra LifeSciences To Acquire the Codman Neurosurgery Business from Johnson & Johnson For $1.045B
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, today announced that it has made a binding offer to acquire the Johnson & Johnson . . .
Posted on 2/15/17
Johnson & Johnson: Strong And Steady Dividend Champ
The market was obviously disappointed by Johnson & Johnson's (NYSE:JNJ) most recent earnings announcement, as the shares dropped about 2% on the news. This is a . . .
Posted on 2/15/17
Teva Management's Brilliant Hidden Message
IntroductionUsually, I make an earnings forecast, act or abstain, and move on to the next. Sometimes, however, the story is so compelling and interesting that I . . .
Posted on 2/15/17
Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal
Teva Pharmaceutical Industries (NYSE:TEVA) hasn't had much good news lately. Shares of the Israel-based drugmaker were hit hard in the second half of 2016.However, the company . . .
Posted on 2/14/17
Quotient Clinical Acquires QS Pharma
Quotient Clinical, the early phase drug development services provider, today announces that it has acquired QS Pharma
Posted on 2/14/17
3 Top Biotech Stocks to Buy on Sale
How can you know if a biotech stock is a bargain?It's not an exact science, but one of the best ways to identify biotech bargains is . . .
Posted on 2/14/17
Teva Pharmaceutical Industries (TEVA) Q4 2016 Results - Earnings Call Transcript
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)Q4 2016 Earnings CallFebruary 13, 2017 8:00 am ETExecutivesKevin C. Mannix - Teva Pharmaceutical Industries Ltd.Sol J. Barer - Teva Pharmaceutical Industries . . .
Posted on 2/14/17
IBB: Merck Joins The Drug Pricing Coalition For Transparency
IntroductionAlthough the political uncertainty has abated, Donald Trump has been able to single handily influence the movement of specific stocks [i.e. Lockheed Martin (NYSE:LMT), Ford (NYSE:F), . . .
Posted on 2/14/17
Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal
Teva Pharmaceutical Industries (NYSE:TEVA) hasn't had much good news lately. Shares of the Israel-based drugmaker were hit hard in the second half of 2016.However, the company . . .
Posted on 2/14/17
Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech
Braeburn Pharmaceuticals was named today by Fast Company as a Top 10 Most Innovative Company in Biotech in conjunction with its annual ranking of the world's . . .
Posted on 2/13/17
Teva Will Report Higher-Than-Expected Income
In my previous earnings estimate analysis, I reached the conclusion that Teva Pharmaceutical (NYSE:TEVA) could not possibly meet its guidance. The specific problem I had was . . .
Posted on 2/13/17
Will Seattle Genetics' Deal With Immunomedics Get Scuttled?
Last week, Seattle Genetics (NASDAQ:SGEN) announced an agreement to license Immunomedics'(NASDAQ:IMMU) IMMU-132, a cancer drug that's already completed midstage phase 2 trials.The deal could be a . . .
Posted on 2/13/17
3 Reasons Johnson & Johnson's Actelion Deal Might Not Be Totally Crazy
There's no question that Johnson & Johnson (NYSE:JNJ) has been one of the most stable companies around. You don't survive and thrive for over 130 years . . .
Posted on 2/12/17
Immunomedics Enters into Global Licensing Agreement with Seattle Genetics
Immunomedics, Inc. (NASDAQ: IMMU) announced that it has entered into an exclusive global licensing agreement with Seattle Genetics, Inc. (NASDAQ: SGEN), an innovative global biotechnology company . . .
Posted on 2/10/17
Valeritas Amends Existing Credit Facility to Extend Payment Obligations
BRIDGEWATER, N.J., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced that it has reached an agreement with its largest lender, Capital Royalty . . .
Posted on 2/9/17
Better Buy: Amgen Inc. vs. Celgene
Amgen (NASDAQ:AMGN) and Celgene (NASDAQ:CELG) are without question two of the most successful biotechs in the world. So far in 2017, Amgen has enjoyed greater success. . . .

